Syndax Pharmaceuticals (SNDX) Other financing activities (2015 - 2022)

Syndax Pharmaceuticals' Other financing activities history runs 8 years deep, the most recent figure standing at $92000.0 for Q1 2022.

• In Q1 2022, Other financing activities rose 16.46% year-over-year to $92000.0; the TTM figure through Mar 2022 stood at $13000.0 (down 18.75% YoY), while the FY2020 annual figure was $1000.0, down 99.45% from the prior year.
• Other financing activities was $92000.0 for Q1 2022 at Syndax Pharmaceuticals, up from -$242000.0 in the prior quarter.
• In the past five years, Other financing activities ranged from a high of $207000.0 in Q4 2018 to a low of -$242000.0 in Q4 2020.
• Historically, Other financing activities has averaged $35941.2 across 5 years, with a median of $63000.0 in 2018.
• The sharpest annual moves came in 2018 and 2020: Other financing activities soared 3500.0% in 2018, then slumped 524.56% in 2020.
• A 5-year view of Other financing activities shows it stood at $207000.0 in 2018, then tumbled by 72.46% to $57000.0 in 2019, then plunged by 524.56% to -$242000.0 in 2020, then changed by 0.0% to -$242000.0 in 2021, then jumped by 138.02% to $92000.0 in 2022.
• The last three Other financing activities figures came in at $92000.0 (Q1 2022), -$242000.0 (Q4 2021), and $99000.0 (Q3 2021), per Business Quant data.